Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

SHE:300519 Revenue

Zhejiang Xinguang Pharmaceutical had revenue of 88.47M CNY in the quarter ending March 31, 2026, a decrease of -5.13%. This brings the company's revenue in the last twelve months to 260.58M, up 0.08% year-over-year. In the year 2025, Zhejiang Xinguang Pharmaceutical had annual revenue of 265.36M, down -0.86%.

• Revenue (ttm): 260.58M
• Revenue Growth: +0.08%
• P/S Ratio: 9.22
• Revenue / Employee: 843.30K
• Employees: 309
• Market Cap: 2.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	265.36M	-2.30M	-0.86%
Dec 31, 2024	267.66M	-2.74M	-1.01%
Dec 31, 2023	270.40M	-81.09M	-23.07%
Jan 1, 2023	351.49M	30.61M	9.54%
Jan 1, 2022	320.88M	37.80M	13.35%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error